GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $63.41 $75.66 Thursday, 18th Apr 2024 CYTK stock ended at $67.00. This is 1.37% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 2.53% from a day low at $66.84 to a day high of $68.53.
90 days $61.33 $84.92
52 weeks $25.98 $110.00

Historical Cytokinetics prices

Date Open High Low Close Volume
2023-09-13 $35.08 $35.20 $34.41 $34.83 721 611
2023-09-12 $34.73 $35.22 $34.26 $35.05 579 707
2023-09-11 $36.06 $36.06 $34.66 $34.73 817 250
2023-09-08 $36.78 $37.10 $35.90 $36.06 699 245
2023-09-07 $35.67 $36.74 $35.67 $36.61 570 100
2023-09-06 $35.57 $36.22 $35.49 $35.81 433 605
2023-09-05 $35.83 $35.87 $34.96 $35.16 581 633
2023-09-01 $35.33 $36.57 $35.33 $36.00 700 462
2023-08-31 $35.00 $35.83 $34.80 $34.94 562 523
2023-08-30 $35.58 $35.72 $34.92 $35.22 410 650
2023-08-29 $35.70 $36.08 $35.21 $35.49 373 379
2023-08-28 $35.06 $35.95 $35.00 $35.88 455 117
2023-08-25 $33.96 $35.26 $33.69 $34.86 554 459
2023-08-24 $32.94 $33.77 $32.75 $33.68 549 123
2023-08-23 $33.58 $34.11 $32.98 $33.05 350 171
2023-08-22 $32.94 $33.65 $32.26 $33.36 441 855
2023-08-21 $32.37 $33.32 $31.80 $32.94 549 521
2023-08-18 $31.66 $32.78 $31.57 $32.44 690 555
2023-08-17 $33.14 $33.23 $31.81 $31.88 505 469
2023-08-16 $32.59 $33.69 $32.16 $33.17 785 036
2023-08-15 $32.32 $32.73 $31.87 $32.71 492 809
2023-08-14 $32.45 $32.60 $31.63 $32.10 550 905
2023-08-11 $32.23 $32.76 $32.10 $32.75 325 067
2023-08-10 $31.70 $32.68 $31.70 $32.49 561 340
2023-08-09 $31.98 $32.45 $31.63 $31.80 548 358
Click to get the best stock tips daily for free!

About Cytokinetics

Cytokinetics Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in pati... CYTK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT